Littérature scientifique sur le sujet « Myelin sheath Diseases Diagnosis »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Myelin sheath Diseases Diagnosis ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Myelin sheath Diseases Diagnosis"
Maegawa, Gustavo H. B. « Lysosomal Leukodystrophies Lysosomal Storage Diseases Associated With White Matter Abnormalities ». Journal of Child Neurology 34, no 6 (13 février 2019) : 339–58. http://dx.doi.org/10.1177/0883073819828587.
Texte intégralVelichko, Ivan A., et Marina A. Barabanova. « GUILLAIN — BARRÉ SYNDROME AS A RELEVANT ISSUE OF NEUROLOGY (A LITERATURE REVIEW) ». Kuban Scientific Medical Bulletin 26, no 2 (17 mai 2019) : 150–61. http://dx.doi.org/10.25207/1608-6228-2019-26-2-150-161.
Texte intégralPopovich, Sofia G., Lyudmila M. Kuzenkova, Olga B. Kondakova, Alexey I. Firumyants, Tatyana V. Podkletnova et Eugeniya V. Uvakina. « A clinical case of POL3A-associated hypomyelinating leukodystrophy with spinal cord lesion with a debut in early childhood ». L.O. Badalyan Neurological Journal 3, no 3 (30 septembre 2022) : 122–26. http://dx.doi.org/10.46563/2686-8997-2022-3-3-122-126.
Texte intégralZhang, Juan, Zhu Chen, Hui Chen, Yan Deng, Song Li et Lian Jin. « Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases ». Biosensors 12, no 12 (24 novembre 2022) : 1074. http://dx.doi.org/10.3390/bios12121074.
Texte intégralLivak, P. E., O. S. Korchuk et N. P. Kozhukh. « Physical rehabilitation and recovery in neurological diseases ». Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2022, no 2 (2022) : 77–80. http://dx.doi.org/10.15407/internalmed2022.02.077.
Texte intégralPourakbari, Hakimeh, Yashar Sarbaz, Jalal Parvin et Mohammad Hossein Vojudi. « Proper Features Extraction from the Multiple Sclerosis Disease Postural Disorders for Decision Support System Definition ». Applied Mechanics and Materials 666 (octobre 2014) : 230–34. http://dx.doi.org/10.4028/www.scientific.net/amm.666.230.
Texte intégralStamate, Iulia Georgiana, Daniel Alexa, Bogdan Ignat et Cristian Dinu Popescu. « Ankylosing spondylitis and multiple sclerosis : a surprising parallel ». Romanian Journal of Neurology 13, no 3 (30 septembre 2014) : 93–102. http://dx.doi.org/10.37897/rjn.2014.3.1.
Texte intégralFedorova, V. S., A. G. Smochilin, A. I. Kulyakhtin, A. A. Yakovlev, M. S. Pushkaryov, A. V. Gavrichenko, E. A. Gavrilova et R. A. Gapeshin. « Charcot - Marie - Toots disease : description of 2 clinical cases of the disease in members of the same family (father and daughter) ». Scientific Notes of the Pavlov University 27, no 2 (25 septembre 2020) : 63–71. http://dx.doi.org/10.24884/1607-4181-2020-27-2-63-71.
Texte intégralVictor, Praznikov. « Diagnosis and Treatment of Alzheimers Disease and Parkinsons Disease with Resonance Medicine ». Journal of Biomedical Research & ; Environmental Sciences 3, no 9 (octobre 2022) : 1000–1006. http://dx.doi.org/10.37871/jbres1544.
Texte intégralРушкевич, Ю. Н., С. А. Лихачев, Л. В. Костоправова, Д. В. Науменко, Т. Г. Гвищ et С. Г. Клюнчик. « Clinical Observation of a Combination of Neurofibromatosis Type I and Multiple Sclerosis ». Неврология и нейрохирургия. Восточная Европа, no 1 (29 avril 2020) : 127–38. http://dx.doi.org/10.34883/pi.2020.10.1.051.
Texte intégralThèses sur le sujet "Myelin sheath Diseases Diagnosis"
Cai, Zhao. « A technique for examining longitudinal and cross sections of teased nerve fibres and its application to human and experimental neuropathy ». Title page, contents and summary only, 2002. http://web4.library.adelaide.edu.au/theses/09PH/09phc1326.pdf.
Texte intégralVana, Adam C. « The oligodendrocyte progenitor response to demyelination / ». Download the dissertation in PDF, 2006. http://www.lrc.usuhs.mil/dissertations/pdf/vana2006.pdf.
Texte intégralSirisi, Dolcet Sònia. « Bases moleculars de la Leucoeocefalopatia Megalencefàllca amb Quists subcorlicals. Utilització de models animals i cel·lulars ». Doctoral thesis, Universitat de Barcelona, 2014. http://hdl.handle.net/10803/284761.
Texte intégralMegalencefalic leukoencephalopathy with subcortical cysts, also known as MLC, is a rare type of leukodystrophy. Currently still unknown pathophysiological mechanism of the disease, and therefore there is no effective treatment possible for patients. There are two genes involved in the MLC disease. Gene was first discovered was MLC1 and this encodes for a membrane protein with the same name. The second gene is called GLIALCAM and encodes for a transmembrane protein type I that also carries the same name. In our group is has been described that GlialCAM acts as a protein ß subunit of MLC1 because it is able to direct and concentrate in the cellular junctions. Moreover, GlialCAM also act as auxiliary subunit of CLC-2 Cl channel as it is capable of modifying the activation and rectification properties of the channel. In this work we have developed two different models to study the physiopathology. The results show that GlialCAM affected by the absence of MLC1. It has been also demonstrated that ClC-2 is implicated in the disease.These results were compared with a patient brian and has been shown that MLC1 is important for the correct location of GlialCAM in the cerbellum. Have also been developed a different cellular models. The results with this models show that GlialCAM and ClC-2 could have a functional role in the process of potassium siphoning.
Arnedo, Llena Tanit. « Paper del canal de clorur CIC-2 en les patologies de la mielina ». Doctoral thesis, Universitat de Barcelona, 2015. http://hdl.handle.net/10803/310220.
Texte intégralMegalencephalic Leukoencephalopathy with subcortical Cysts (MLC) is a rare type of vacuolating leukodystrophy. Currently still unknown pathophysiological mechanism of the disease, and therefore there is no effective treatment possible for patients. There are two genes involved in the MLC disease. Gene was first discovered was MLC1 and this encodes for a membrane protein with the same name. The second gene is called GLIALCAM and encodes for a transmembrane protein type I that also carries the same name. In our group is has been described that GlialCAM acts as a protein ß subunit of MLC1 because it is able to direct and concentrate in the cellular junctions. Moreover, GlialCAM also act as auxiliary subunit of CLC-2 Cl channel as it is capable of modifying the activation and rectification properties of the channel. Recently, mutations in ClC-2 have been associated with a rare type of vacuolating leukodystrophy. The principal aim of this study is to advance in the knowledge of GlialCAM and ClC-2 in the glial cells and into the pathogenesis of vacuolating leukodistrophies. To accomplish the study, the group performed a biochemical and funcional characterization of new mutations in GLIALCAM associated with MLC. We suggest that the HEPACAM mutations described up to now can be classified in several groups. Some mutations can affect GlialCAM protein expression, affect its ability to cis-homooligomerize and consequently reduce their localization in cell–cell junctions. Some mutations can affect specifically only transinteractions between GlialCAM molecules or may be unstable without MLC1 and finally some mutations affect the protein internalization. Parallel progress was made in the biochemical relationship between GlialCAM and ClC-2 from biochemical and functional studies of mutations in CLCN2 associated with vacuolating leukodystrophies. GlialCAM has been observed to increase ClC-2 function by the modification of its gating and the stabilization of ClC-2 in the plasma membrane. In addition, the stabilization requires a previous formation of GlialCAM’s homocomplexes. Finally, a knock-down model of the CLC-2 protein was generated and characterized to deepen the role of CLC -2 astrocytes. As well as progress was made in biochemistry and functional relationship between CLC -2 and GlialCAM in the astrocitic physiology. It has been reported that astrocytes cultured in conditions of high concentrations of K + , similar to what happens in situations of high neuronal activity , CLC -2 translocates from the Golgi apparatus to the cell membrane , changing the its functional properties for the purpose of GlialCAM . However, in MLC1 deficient astrocytes, CLC -2 is retained intracellularly. This would indicate that these proteins could play a role in the potassium siphoning, and therefore the relocation of CLC -2 could lead to disorder in the homeostasis of water and ions.
Santos, Vives Alicia. « Estudio neuropsicológico, neurorradiológico y clínico en el hipercortisolismo endógeno = Neuropsychological, neuroradiological and clinical study in endogenous hypercortisolism ». Doctoral thesis, Universitat de Barcelona, 2015. http://hdl.handle.net/10803/384710.
Texte intégralEl síndrome de Cushing endógeno es una enfermedad rara debida a un exceso de cortisol circulante. El exceso crónico de cortisol puede provocar una serie de alteraciones que no en todos los casos revierten tras la curación hormonal, y que incluyen disminución del volumen cerebral, alteraciones neuropsicológicas y del estado de ánimo y riesgo cardiovascular elevado. Esta tesis pretende estudiar algunos de los efectos que provoca el síndrome de Cushing a nivel cerebral, analizando su relación con otros parámetros clínicos. Concretamente, los objetivos de la tesis incluyen por un lado analizar el volumen cerebelar en los pacientes con síndrome de Cushing, así como establecer su relación con el rendimiento neuropsicológico, los niveles de cortisol y otros parámetros clínicos. Por otro lado, se pretende analizar la presencia de lesiones de sustancia blanca cerebral en los pacientes con síndrome de Cushing y la relación entre riesgo cardiovascular, lesiones de sustancia blanca, rendimiento neuropsicológico y volumen cerebral. Se encontraron menores volúmenes del córtex cerebelar bilateral en los pacientes activos, pero no en los pacientes curados, en comparación con los controles. El córtex cerebelar correlacionó positivamente con el rendimiento en memoria visual y la calidad de vida y negativamente con la edad en el momento del diagnóstico y el nivel de triglicéridos circulantes. Los pacientes activos presentaban peor rendimiento a nivel de memoria, y ambos grupos de pacientes presentaban mayores niveles de ansiedad y depresión que los controles sanos. Por otro lado, los pacientes en remisión, pero no los pacientes activos presentaron mayor nivel de lesiones de sustancia blanca cerebral que los controles sanos. Estas lesiones estaban relacionadas con los niveles de tensión diastólica y la duración de la hipertensión. Los pacientes en remisión que tomaban hidrocortisona presentaban mayor nivel de lesiones que los pacientes en remisión que no tomaban el fármaco. Finalmente ambos grupos de pacientes (activos y en remisión) presentaban mayor riesgo cardiovascular que los controles sanos. El riesgo cardiovascular correlacionó negativamente con la función cognitiva y el volumen cerebral en los pacientes en remisión. En conclusión, el síndrome de Cushing determina diferentes comorbilidades en las distintas fases de la enfermedad. Algunas de las alteraciones halladas en los pacientes activos podrían ser al menos parcialmente reversibles, aunque el riesgo cardiovascular asociado a la enfermedad puede llevar a otras comorbilidades en el futuro si no se controla. Estos datos remarcan la importancia de proporcionar un soporte psicológico a los pacientes en caso necesario y de controlar el riesgo vascular para prevenir la posible afectación cerebral futura y reducir el riesgo de complicaciones cardiovasculares.
Cai, Zhao. « A technique for examining longitudinal and cross sections of teased nerve fibres and its application to human and experimental neuropathy / a thesis submitted by Zhao Cai ». Thesis, 2002. http://hdl.handle.net/2440/21761.
Texte intégralix, 225, vii leaves : ill. (some col.) ; 30 cm.
A new method is described that enables longitudinal and cross sections of an individual nerve fibre to be cut at multiple specified sites along the fibre by use of an unique marker system. The method is particularly useful for the correlative study of myelin-axon relationships
Thesis (Ph.D.)--University of Adelaide, Dept. of Medicine, 2002
Livres sur le sujet "Myelin sheath Diseases Diagnosis"
Knaap, Marjo S. van der. Magnetic resonance of myelin, myelination, and myelin disorders. 2e éd. Berlin : Springer, 1995.
Trouver le texte intégralValk, J. Magnetic resonance of myelin, myelination, and myelin disorders. Berlin : Springer-Verlag, 1989.
Trouver le texte intégralMarjo S. van der Knaap. Magnetic resonance of myelination and myelin disorders. 3e éd. Berlin : Springer, 2005.
Trouver le texte intégralNATO Advanced Research Workshop on a Multidisciplinary Approach to Myelin Diseases (1986 Rome, Italy). A multidisciplinary approach to myelin diseases. New York : Plenum Press, 1987.
Trouver le texte intégralD, Duncan I., Skoff R. P, Colman D et New York Academy of Sciences., dir. Myelination and dysmyelination. New York, N.Y : New York Academy of Sciences, 1990.
Trouver le texte intégralBisese, John H. Pediatric cranial MRI : An atlas of normal development. New York : Springer-Verlag, 1994.
Trouver le texte intégralJ, Vinken P., et Koetsier Johan C, dir. Demyelinating diseases. Amsterdam : Elsevier Science Publishers, 1985.
Trouver le texte intégralSatellite Symposium on Myelination and Demyelination : Implications for Multiple Sclerosis (1987 Vancouver, B.C.). Myelination and demyelination : Implications for multiple sclerosis. New York : Plenum Press, 1989.
Trouver le texte intégralJeremić, Branislav. Primary Optic Nerve Sheath Meningioma. Berlin, Heidelberg : Springer-Verlag, 2008.
Trouver le texte intégralValk, Jacob, et Marjo S. van der Knaap. Magnetic Resonance of Myelin, Myelination and Myelin Disorders. Springer London, Limited, 2013.
Trouver le texte intégralChapitres de livres sur le sujet "Myelin sheath Diseases Diagnosis"
Zalc, B., M. Monge et C. Jacque. « Oligodendroglial Emergence and Deposition of Four Major Myelin Constituents in the Myelin Sheath During Development : An in Vivo Study ». Dans A Multidisciplinary Approach to Myelin Diseases, 77–85. Boston, MA : Springer US, 1987. http://dx.doi.org/10.1007/978-1-4757-0354-2_6.
Texte intégralSingh, Ashok Kumar, et J. N. Srivastava. « Sheath Blight Disease of Paddy and Their Management ». Dans Recent Advances in the Diagnosis and Management of Plant Diseases, 91–99. New Delhi : Springer India, 2015. http://dx.doi.org/10.1007/978-81-322-2571-3_9.
Texte intégralLassmann, Hans, Raymond A. Sobel et Danielle Seilhean. « Multiple Sclerosis and Related Inflammatory Demyelinating Diseases ». Dans Escourolle and Poirier's Manual of Basic Neuropathology, 161–72. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199929054.003.0007.
Texte intégralAcosta, Maria T. « Neurofibromatosis Type 1 : Cognitive and Behavioral Phenotype : Diagnosis and Treatment ». Dans Cognitive and Behavioral Abnormalities of Pediatric Diseases. Oxford University Press, 2010. http://dx.doi.org/10.1093/oso/9780195342680.003.0045.
Texte intégralDoğan, Serhat, Selim Sözen, Burhan Hakan Kanat, Gökhan Söğütlü, Mehmet Gençtürk et Hasan Erdem. « Rectus Sheath Hematoma ». Dans Trauma and Emergency Surgery. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.101438.
Texte intégralTobin, W. Oliver. « Diagnosis of Multiple Sclerosis ». Dans Mayo Clinic Neurology Board Review, sous la direction de Kelly D. Flemming, 540–47. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780197512166.003.0065.
Texte intégralSCHRAMME, M. « Diseases of the Digital Synovial Sheath, Palmar Annular Ligament, and Digital Annular Ligaments ». Dans Diagnosis and Management of Lameness in the Horse, 674–84. Elsevier, 2003. http://dx.doi.org/10.1016/b978-0-7216-8342-3.50082-6.
Texte intégralSchramme, Michael C., et Roger K. W. Smith. « Diseases of the Digital Flexor Tendon Sheath, Palmar Annular Ligament, and Digital Annular Ligaments ». Dans Diagnosis and Management of Lameness in the Horse, 764–76. Elsevier, 2011. http://dx.doi.org/10.1016/b978-1-4160-6069-7.00074-2.
Texte intégralZhou, Xin-Gen, Dongyan Zhang et Fenfang Lin. « UAV Remote Sensing : An Innovative Tool for Detection and Management of Rice Diseases ». Dans Diagnostics of Plant Diseases [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.95535.
Texte intégralActes de conférences sur le sujet "Myelin sheath Diseases Diagnosis"
Coelho, Elton Marcio Marques, Mônica Cardoso do Amaral, João Mário Abrantes Aguiar Dourado et Carla Jamile Jabar Menezes. « Clinical-epidemiological profile of patients hospitalized with Multiple Sclerosis in the state of Sao Paulo ». Dans XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.541.
Texte intégralCoelho, Elton Marcio Marques, Mônica Cardoso do Amaral, João Mário Abrantes Aguiar Dourado et Carla Jamile Jabar Menezes. « Clinical-epidemiological profile of patients hospitalized with Multiple Sclerosis in the state of Sao Paulo ». Dans XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.549.
Texte intégralRocha, Isadora Souza, Paola Nabhan Leonel dos Santos, João Guilherme Bochnia Küster, Maria Angélica Vieira Lizama, Vinícius Riegel Giugno, Hélio Afonso Ghizoni Teive et Salmo Raskin. « Pelizaeus-Merzbacher Disease with Novel Variant : Case Report ». Dans XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.672.
Texte intégral